Liposomes as a potential ocular delivery system of distamycin A

International Journal of Pharmaceutics

Volumn 492, Issue 1-2, 2015, Pages 120-126

  Chetoni, Patrizia ^a   Monti, Daniela ^a   Tampucci, Silvia ^a   Matteoli, Barbara ^a   Ceccherini Nelli, Luca ^a   Subissi, Alessando ^a   Burgalassi, Susi ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Antiviral; Cytotoxicity; Distamycin A; Liposome; Pharmacokinetic; Rabbit

Indexed keywords

DISTAMYCIN A; LIPOSOME; ANTIVIRUS AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CELL PROLIFERATION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG PENETRATION; ELIMINATION RATE CONSTANT; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IC50; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; VERO CELL LINE; ZETA POTENTIAL; ANIMAL; AQUEOUS HUMOR; BIOAVAILABILITY; CELL LINE; CELL SURVIVAL; CHLOROCEBUS AETHIOPS; CORNEA; DRUG EFFECTS; INTRAOCULAR DRUG ADMINISTRATION; LACRIMAL FLUID; METABOLISM; RABBIT;

ADMINISTRATION, OPHTHALMIC; ANIMALS; ANTIVIRAL AGENTS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CELL LINE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CORNEA; DISTAMYCINS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; LIPOSOMES; MALE; RABBITS; TEARS; VERO CELLS;

EID: 84937510863     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.05.055     Document Type: Article

References (40)

1. L.J. Al-Dujaili, P.P. Clerkin, C. Clement, H.E. McFerrin, P.S. Bhattacharjee, E.D. Varnell, H.E. Kaufman, and J.M. Hill Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol. 6 2011 877 890
2. J. Araújo, E. Gonzalez, M.A. Egea, M.L. Garcia Eliana, and B. Souto Nanomedicines for ocular NSAIDs: safety on drug delivery Nanomedicine 5 2009 394 401
3. R. Agarwal, I. Iezhitsa, P. Agarwal, N.A. Abdul Nasir, N. Razali, R. Alyautdin, and N.M. Ismail Liposomes in topical ophthalmic drug delivery: an update Drug Deliv. 12 2014 1 17
4. S.S. Broyles, M. Kremer, and B.A. Knutson Antiviral activity of distamycin A against vaccinia virus is the result of inhibition of postreplicative mRNA synthesis J. Virol. 78 2004 2137 2141
5. S. Burgalassi, P. Chetoni, D. Monti, and M.F. Saettone Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines Toxicol. Lett. 122 2001 1 8
6. S. Burgalassi, D. Monti, A. Brignoccoli, O. Fabiani, C. Lenzi, A. Pirone, and P. Chetoni Development of cultured rabbit corneal epithelium for drug permeation studies: a comparison with excised rabbit cornea J. Ocul. Pharmacol. Ther. 20 2004 518 532
7. A.M. Casazza, A. Fioretti, M. Ghione, M. Soldati, and M.A. Verini Distamycin A, a new antiviral antibiotic Antimicrob. Agents Chemother. 5 1966 593 598
8. P. Chandra, A. Goetz, A. Wacker, M.A. Verini, A.M. Casazza, and M. Ghione Some structural requirements for the antibiotic action of distamycins FEBS Lett. 16 1971 249 252
9. P. Chetoni, S. Rossi, S. Burgalassi, D. Monti, S. Mariotti, and M.F. Saettone Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits J. Ocul. Pharmacol. Ther. 20 2004 169 177
10. P. Chetoni, S. Burgalassi, D. Monti, M. Najarro, and E. Boldrini Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity J. Drug Deliv. Sci. Technol. 17 2007 43 48
11. R. Cortesi, and E. Esposito Distamycins: strategies for possible enhancement of activity and specificity Mini Rev. Med. Chem. 10 2010 217 230
12. R. Cortesi, R. Romagnoli, E. Menegatti, E. Esposito, F. Cervellati, and C. Nastruzzi Liposomes containing distamycins: preparation, characterization and antiproliferative activity Drug Deliv. 11 2004 83 88
13. R. Cortesi, R. Romagnoli, M. Drechsler, E. Menegatti, A.N. Zaid, L. Ravani, and E. Esposito Liposomes- and ethosomes-associated distamycins: a comparative study J. Liposome Res. 20 2010 277 285
14. J. De Leeuw, H.C. De Vijlder, P. Bjerring, and H.A. Neumann Liposomes in dermatology today J. Eur. Acad. Dermatol. Venereol. 23 2009 505 516
15. S. Ebrahim, G. Peyman, and P.J. Lee Applications of liposomes in ophthalmology Surv. Ophthalmol. 50 2005 167 182
16. G.M. El Maghraby, B.W. Barry, and A.C. Williams Liposomes and skin: from drug delivery to model membranes Eur. J. Pharm. Sci. 34 2008 203 222
17. R. Gaudana, J. Jwala, S.H. Boddu, and A.K. Mitra Recent perspectives in ocular drug delivery Pharm. Res. 26 2009 1197 1216
18. R. Gaudana, H.K. Ananthula, A. Parenky, and A.K. Mitra Ocular drug delivery AAPS J. 12 2010 348 360
19. M.T. Green, E.C. Dunkel, and R.J. Courtney Detection of herpes simplex virus induced polypeptides in rabbit trigeminal ganglia Investig. Ophthalmol. Vis. Sci. 25 1984 1436 1440
20. G. Gregoriadis, and A.T. Florence Liposomes in drug delivery: clinical, diagnostic and ophthalmic potential Drugs 45 1993 15 28
21. F.S. Habib, E.A. Fouad, M.S. Abdel-Rhaman, and D. Fathalla Liposomes as an ocular delivery system of fluconazole: in-vitro studies Acta Ophthalmol. 88 2010 901 904
22. H.C. Korting, and M. Schäfer-Korting Carriers in the topical treatment of skin disease Handb. Exp. Pharmacol. 197 2010 435 468
23. J.J. Leary, R. Wittrock, R.T. Starisky, A. Weinberg, and M.J. Levin Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines Antimicrob. Agents Chemother. 3 2002 762 768
24. V.H.L. Lee, K.A. Takemoto, and D.S. Iimoto Precorneal factors influencing the ocular distribution of topically applied liposomal inulin Curr. Eye Res. 3 1984 585 591
25. A. Martin, and M. Clynes Comparisons of five microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays Cytotechnology 11 1993 49 58
26. B. Matteoli, S. Bernardini, R. Iuliano, S. Parenti, G. Freer, F. Broccolo, A. Baggiani, A. Subissi, F. Arcamone, and L. Ceccherini-Nelli In vitro antiviral activity of distamycin A against clinical isolates of Herpes Simplex Virus 1 and 2 from transplanted patients Intervirology 51 2008 166 172
27. R. Mentel, E. Matthes, M. Janta-Lipinski, and U. Wegner Fluorescent focus reduction assay for the screening of antiadenoviral agents J. Virol. Methods 59 1996 99 104
28. D. Monti, U. Herranz, L. Dal Bo, and A. Subissi Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects J. Eur. Acad. Dermatol. Venereol. 27 2013 153 158
29. M.I. Nounou, L.K. El-Khordagui, N.A. Khalafallah, and S.A. Khalil Liposomal formulation for dermal and transdermal drug delivery: past, present and future Recent Pat. Drug Deliv. Formul. 2 2008 8 18
30. J.A. Omotosho, T.L. Whateley, and A.T. Florence Methotrexate transport from the internal phase of multiple W/O/W emulsions J. Microencapsul. 6 1989 183 192
31. J.S. Pepose, T.L. Keadle, and L.A. Morrison Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy Am. J. Ophthalmol. 141 2006 547 557.e2
32. M. Rawas-Qalaji, and C.A. Williams Advances in ocular drug delivery Curr. Eye Res. 37 2012 345 356
33. S. Reichl Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro J. Pharm. Pharmacol. 60 2008 299 307
34. P. Ritger, and N. Peppas A simple equation for description of solute release II. Fickian and anomalous release from swellable devices J. Control. Release 5 1987 37 42
35. B. Stella, S. Arpicco, F. Rocco, S. Burgalassi, N. Nicosia, S. Tampucci, P. Chetoni, and L. Cattel Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits Eur. J. Pharm. Biopharm. 80 2012 39 45
36. R.E.J. Stratford, D.C. Yang, M.A. Redell, and V.H.L. Lee Ocular distribution of liposome encapsulated epinephrine and inulin in the albino rabbit Curr. Eye Res. 2 1983 377 386
37. F. Szoka Jr., and D. Papahadjopoulos Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation Proc. Natl. Acad. Sci. U. S. A. 75 1978 4194 4198
38. H.S. Toma, A.T. Murina, R.G. Areaux, D.M. Neumann, P.S. Bhattacharjee, T.P. Foster, H.E. Kaufman, and J.M. Hill Ocular HSV-1 latency, reactivation and recurrent disease Semin. Ophthalmol. 23 2008 249 273
39. M.A. Verini, G. D'Amico, A. Sanfilippo, and F. Arcamone The effect of distamycin A on some biochemical functions of tissue cultures infected with herpes simplex virus Farmaco Sci. 31 1976 705 713
40. S. Yu, Q.-M. Wang, X. Wang, D. Liu, W. Zhang, T. Ye, X. Yang, and W. Pan Liposome incorporated ion sensitive in situ gels for ophthalmic delivery of timolol maleate Int. J. Pharm. 480 2015 128 136